Proprietary DNA synthesis technology Twist Bioscience has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA, offering precision at scale and enabling cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. This technology can be marketed to life science researchers in need of synthetic genes, oligo pools, and NGS target enrichment for various applications in medicine, agriculture, and industrial chemicals.

Strategic partnerships Twist Bioscience has engaged in strategic partnerships with companies like XOMA Co. and Absci, focusing on novel therapeutic antibody development and technology collaborations. Leveraging these partnerships, sales development representatives can explore opportunities to offer collaborative solutions and expand the reach of Twist Bioscience's products and services.

Recent product launches Twist Bioscience recently launched the Transaminase Enzyme Screening Kit, showcasing its continuous innovation in DNA synthesis technology. Sales professionals can capitalize on these new product offerings to introduce advanced solutions to customers and prospects looking to enhance their research capabilities and scientific outcomes.

Key personnel appointments The appointment of Mike Fero as Chief Information Officer brings strategic leadership to Twist Bioscience. Sales development representatives can leverage the credibility and expertise of key personnel like Mike Fero to build relationships, drive sales conversations, and demonstrate the company's commitment to excellence in synthetic DNA production.

Financial strength and growth potential With revenues estimated between $100 million to $1 billion and significant funding of $250 million, Twist Bioscience demonstrates financial stability and growth potential. Business development professionals can emphasize the company's financial health and capacity for expansion to attract investors, secure partnerships, and drive sales opportunities in the competitive biotechnology research market.